Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea
- PMID: 25493025
- PMCID: PMC4258581
- DOI: 10.3748/wjg.v20.i45.17120
Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea
Abstract
Aim: To investigate differences of clinical characteristics and disease courses between familial and sporadic inflammatory bowel disease (IBD) patients.
Methods: We obtained clinical data on Crohn's disease (CD) (n = 691) and ulcerative colitis (n = 1113) from a tertiary referral medical center between 2005 and 2012. Seventeen patients (2.5%) with CD and 27 patients (2.4%) with ulcerative colitis (UC) were identified as having a familial history of IBD, including the first and second degree relatives. For each control case, three times the number of age-, sex-, and diagnosis year-matched CD and UC patients, without a family history of IBD, were randomly selected in this case control study.
Results: There were no significant differences in age or main symptom at diagnosis, extraintestinal manifestation, location/extent, behavior of disease activity, number of hospitalizations, number of operations, operation type, number of relapses, or oral medical treatment between familial and sporadic CD and UC patients. Median (min-max) follow-up periods after diagnosis of familial CD and sporadic CD patients were 84 (24-312) and 36 (8-240) mo, respectively (P = 0.008). Familial CD patients more frequently used anti-tumor necrosis factor (TNF) antibodies compared to sporadic CD patients (17.6% vs 0%, P = 0.014).
Conclusion: In conclusion, a family history of IBD does not seem to be an important predictive factor affecting clinical characteristics or disease course even if there is a more frequent use of anti-TNF antibodies in familial CD patients compared to sporadic CD patients.
Keywords: Clinical characteristics; Crohn’s disease; Family history; Inflammatory bowel disease; Ulcerative colitis.
Figures
Similar articles
-
Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977-2011.Inflamm Bowel Dis. 2015 Dec;21(12):2825-32. doi: 10.1097/MIB.0000000000000545. Inflamm Bowel Dis. 2015. PMID: 26288000
-
Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.World J Gastroenterol. 2016 Jun 14;22(22):5267-75. doi: 10.3748/wjg.v22.i22.5267. World J Gastroenterol. 2016. PMID: 27298570 Free PMC article.
-
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.Dan Med J. 2014 Jan;61(1):B4778. Dan Med J. 2014. PMID: 24393595
-
CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.Eur J Gastroenterol Hepatol. 2007 Jun;19(6):449-59. doi: 10.1097/01.meg.0000236887.44214.6a. Eur J Gastroenterol Hepatol. 2007. PMID: 17489054 Review.
-
Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.World J Gastroenterol. 2014 Nov 7;20(41):15037-48. doi: 10.3748/wjg.v20.i41.15037. World J Gastroenterol. 2014. PMID: 25386052 Free PMC article. Review.
Cited by
-
Differences of clinical phenotype between familial and sporadic Crohn's disease in East China.Int J Colorectal Dis. 2024 Jul 13;39(1):107. doi: 10.1007/s00384-024-04688-7. Int J Colorectal Dis. 2024. PMID: 39001900 Free PMC article.
-
Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry.J Clin Med. 2025 May 12;14(10):3352. doi: 10.3390/jcm14103352. J Clin Med. 2025. PMID: 40429348 Free PMC article.
-
Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis.Intest Res. 2017 Jul;15(3):388-394. doi: 10.5217/ir.2017.15.3.388. Epub 2017 Jun 12. Intest Res. 2017. PMID: 28670236 Free PMC article.
-
Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.Inflamm Intest Dis. 2017 Nov;2(2):102-115. doi: 10.1159/000465522. Epub 2017 Apr 8. Inflamm Intest Dis. 2017. PMID: 30018961 Free PMC article. Review.
-
Does the road to primary prevention of inflammatory bowel disease start from childhood?JGH Open. 2022 Jun 22;6(6):365-368. doi: 10.1002/jgh3.12782. eCollection 2022 Jun. JGH Open. 2022. PMID: 35774343 Free PMC article. No abstract available.
References
-
- Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol. 2007;102:1077–1083. - PubMed
-
- Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol. 2006;101:993–1002. - PubMed
-
- Peeters M, Cortot A, Vermeire S, Colombel JF. Familial and sporadic inflammatory bowel disease: different entities? Inflamm Bowel Dis. 2000;6:314–320. - PubMed
-
- Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol. 2004;18:525–539. - PubMed
-
- Park JB, Yang SK, Byeon JS, Park ER, Moon G, Myung SJ, Park WK, Yoon SG, Kim HS, Lee JG, et al. Familial occurrence of inflammatory bowel disease in Korea. Inflamm Bowel Dis. 2006;12:1146–1151. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical